Experts gather in Bali to adress HIV/AIDS in Asia, the Pacific

The ninth International Congress on AIDS in Asia and the Pacific (ICAAP) kicked off Monday in Bali, Indonesia, bringing together health experts representing 65 nations to discuss ways to achieve universal access to HIV/AIDS treatment, Agence France-Presse reports (8/9).

"Two of the main talking points are expected to be how to reach the 75 percent of sufferers who are not receiving treatment, and how to stop the disease spreading among intravenous drug users," AFP/Asiaone.com reports. "The congress, which runs until Thursday, will also demand commitment from governments to tackle a disease that killed 380,000 people across Asia in 2007, [Congress Chairman Zubairi] Djoerban said," AFP/Asiaone.com writes (8/9).

Reuters reports that health experts addressed the need to connect women and children with HIV/AIDS treatments and also "called for repeal of outdated laws criminalizing prostitution and homosexuality so that people suffering from HIV/AIDS or at risk from the disease could get medical treatment," the news service writes.

The AAP/Sydney Morning Herald examines appeals by the Australian Federation of AIDS Organizations for federal funding for regional HIV/AIDS prevention programs (8/9).


Kaiser Health NewsThis article was reprinted from khn.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New two-dose HIV vaccine strategy shows promise for stronger immune response